Premium
A serine loop in tissue factor mediates substrate selectivity by the tissue factor–factor VIIa complex
Author(s) -
Birkle Fabienne,
Morrissey James H.
Publication year - 2021
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/jth.15087
Subject(s) - tissue factor , serine , thrombin , factor x , chemistry , selectivity , factor ix , mutant , biochemistry , biology , enzyme , coagulation , platelet , gene , immunology , medicine , catalysis
Essentials How the tissue factor–factor VIIa complex selects between different substrates is not well understood. We investigated a serine loop in tissue factor and its role in substrate selectivity. The tissue factor serine loop is selective for factor X over factor IX. Substrate selectivity is facilitated by differential regulation of the nearby tissue factor exosite.Abstract Background The tissue factor–factor VIIa (TF–FVIIa) complex is the physiologic activator of blood clotting and plays a major role in many thrombotic diseases. TF–FVIIa drives clotting through proteolytic cleavage of its major protein substrates, factor IX (FIX) and factor X (FX). However, it remains unclear how TF–FVIIa exhibits selectivity between these substrates. We previously showed that TF residues adjacent to the putative substrate binding site of TF (“exosite”) facilitate FX activation, but the role of these residues in substrate selectivity had not been tested. Objectives We hypothesized that a TF serine loop (residues S160‐S163) mediates substrate selectivity by the TF–FVIIa complex. Methods We generated TF serine loop and exosite mutants. The mutants were tested in FIX and FX enzyme activation assays as well as thrombin generation assays. Results Changes in the length of the serine loop affected rates of FIX and FX activation very differently. FX activation was decreased by up to 200‐fold when the loop length was changed by just one residue. In contrast, FIX activation was largely unaffected. Substrate selectivity was also detected in thrombin generation assays. Activation assays with TF serine loop and exosite double mutants revealed that the serine loop has no effect on the exosite during FIX activation. In contrast, the serine loop regulates the exosite during FX activation. Conclusions Our results provide new insights into how the TF‐FVIIa complex actively selects between its major protein substrates, which is mediated by a TF serine loop.